Abstract
FIGHTING HCV: Two potent antiviral analogues were developed from a previously identified lead as novel agents against hepatitis C virus. Their potency and selectivity (5 n: IC50 =0.013 μM and EC50 =0.018 μM; 5 t: IC50 =0.007 μM and EC50 =0.024 μM) make them good candidates for further development as antiviral agents.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antiviral Agents / chemical synthesis
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Cell Line
-
Cell Survival / drug effects
-
Dose-Response Relationship, Drug
-
Hepacivirus / drug effects*
-
Humans
-
Indazoles / chemical synthesis
-
Indazoles / chemistry
-
Indazoles / pharmacology*
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Structure-Activity Relationship
-
Virus Replication / drug effects
Substances
-
Antiviral Agents
-
Indazoles